735 related articles for article (PubMed ID: 19743450)
21. Neuropsychological Impairments and Their Cognitive Architecture in Mild Cognitive Impairment (MCI) with Lewy Bodies and MCI-Alzheimer's Disease.
Ciafone J; Thomas A; Durcan R; Donaghy PC; Hamilton CA; Lawley S; Roberts G; Colloby S; Firbank MJ; Allan L; Petrides G; Taylor JP; O'Brien JT; Gallagher P
J Int Neuropsychol Soc; 2022 Oct; 28(9):963-973. PubMed ID: 34666864
[TBL] [Abstract][Full Text] [Related]
22. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
[TBL] [Abstract][Full Text] [Related]
23. Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile.
Donaghy PC; Ciafone J; Durcan R; Hamilton CA; Barker S; Lloyd J; Firbank M; Allan LM; O'Brien JT; Taylor JP; Thomas AJ
Psychol Med; 2022 Apr; 52(6):1147-1155. PubMed ID: 32840196
[TBL] [Abstract][Full Text] [Related]
24. Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
Whitwell JL; Petersen RC; Negash S; Weigand SD; Kantarci K; Ivnik RJ; Knopman DS; Boeve BF; Smith GE; Jack CR
Arch Neurol; 2007 Aug; 64(8):1130-8. PubMed ID: 17698703
[TBL] [Abstract][Full Text] [Related]
25. Prospective predictors of decline
Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
[TBL] [Abstract][Full Text] [Related]
26. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
27. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study.
Molano J; Boeve B; Ferman T; Smith G; Parisi J; Dickson D; Knopman D; Graff-Radford N; Geda Y; Lucas J; Kantarci K; Shiung M; Jack C; Silber M; Pankratz VS; Petersen R
Brain; 2010 Feb; 133(Pt 2):540-56. PubMed ID: 19889717
[TBL] [Abstract][Full Text] [Related]
28. Spatial navigation deficit in amnestic mild cognitive impairment.
Hort J; Laczó J; Vyhnálek M; Bojar M; Bures J; Vlcek K
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4042-7. PubMed ID: 17360474
[TBL] [Abstract][Full Text] [Related]
29. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA
Lancet Neurol; 2016 Aug; 15(9):934-943. PubMed ID: 27312738
[TBL] [Abstract][Full Text] [Related]
30. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.
Nag S; Yu L; Capuano AW; Wilson RS; Leurgans SE; Bennett DA; Schneider JA
Ann Neurol; 2015 Jun; 77(6):942-52. PubMed ID: 25707479
[TBL] [Abstract][Full Text] [Related]
32. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
33. Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease.
King E; O'Brien JT; Donaghy P; Morris C; Barnett N; Olsen K; Martin-Ruiz C; Taylor JP; Thomas AJ
Int Psychogeriatr; 2019 Apr; 31(4):551-560. PubMed ID: 30854988
[TBL] [Abstract][Full Text] [Related]
34. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
[TBL] [Abstract][Full Text] [Related]
35. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.
Ranginwala NA; Hynan LS; Weiner MF; White CL
Am J Geriatr Psychiatry; 2008 May; 16(5):384-8. PubMed ID: 18448850
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies.
Liu C; Liu S; Wang X; Ji Y
Aging Ment Health; 2021 Nov; 25(11):2011-2017. PubMed ID: 32896168
[TBL] [Abstract][Full Text] [Related]
37. Neuropathological profile of mild cognitive impairment from a population perspective.
Stephan BC; Matthews FE; Hunter S; Savva GM; Bond J; McKeith IG; Ince P; Brayne C;
Alzheimer Dis Assoc Disord; 2012; 26(3):205-12. PubMed ID: 21946014
[TBL] [Abstract][Full Text] [Related]
38. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies.
Hansen LA; Samuel W
Neurology; 1997 Jan; 48(1):126-32. PubMed ID: 9008507
[TBL] [Abstract][Full Text] [Related]
39. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.
Brown DF; Dababo MA; Bigio EH; Risser RC; Eagan KP; Hladik CL; White CL
J Neuropathol Exp Neurol; 1998 Jan; 57(1):39-46. PubMed ID: 9600196
[TBL] [Abstract][Full Text] [Related]
40. Much of late life cognitive decline is not due to common neurodegenerative pathologies.
Boyle PA; Wilson RS; Yu L; Barr AM; Honer WG; Schneider JA; Bennett DA
Ann Neurol; 2013 Sep; 74(3):478-89. PubMed ID: 23798485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
